Hospitals should plan for drug needs using accountable methods to avoid empty drugs. Good drug planning can improve pharmaceutical stock control in hospitals. The purpose of this study was to find out about the application of consumption methods with EOQ, MMSL and ABC-VEN forecasting in the management of pharmaceutical supplies in hospitals. This study used retrospective mix-method data, quantitative data and qualitative primary data. The research was conducted at RSU Royal Prima Marelan. The results showed that drug supply control using the EOQ method of getting drugs reordered: cefixime 200MG ordered at 447, ondacetron 4MG 740, gabapentin 300MG 706, ranitidine 25MG 1467, novorapid flexpen / 5" 42. In the SS method, the number of drugs available at delivery, cefixime 200MG should be 627 drugs at the time of shipment, ondacetron 4MG should be 522, gabapentin 300MG should be 470, ranitidine 25MG should be 940, and novorapid flexpen/5" should be 26. In the ROP method the drug was reordered at cefixime 200MG it was reordered when the stock was 447 and the quantity ordered was 12027, ondacetron 4MG 740 and 10000, gabapentin 300MG 706 and 9020, ranitidine 25MG 1467 and 18040, novorapid flexpen 42 and 502. In the ABC method, group A as many as 59 types 70.59% with a total investment of 70.59% drug use and an investment value of IDR 606,511,106, group B 64 drug investment 20.33% investment 20.33% drug use investment 174,722,327, group C 146 types (9.08%) investment 9.08% drug use and investment 78,028,263.
AbstrakOsteoporosis merupakan suatu kelainan metabolik tulang yang sering timbul, kondisi ini ketika tulang secara perlahan kehilangan kepadatannya disertai transformasi mikroarsitektur jaringan tulang yang dapat mengakibatkan penurunan kekuatan tulang sehingga kecenderungan untuk mengalami fraktur. Salah satu penyebab yang berpengaruh terhadap terjadinya penurunnya massa tulang ialah Indeks Massa Tubuh (IMT). IMT merupakan cara yang diterapkan untuk penilaian status gizi yang cukup praktis. Dimana IMT ini dapat digunakan untuk menentukan status berat badan sesorang dengan kategori berupa nilai IMT < 18,5 kg/ = berat badan kurang, nilai IMT 18,5 - 22,9 kg/ = normal, nilai IMT 23-24,9 kg/ = obesitas ringan, nilai IMT 25,0 - 29,9 kg/ = obesitas sedang, nilai IMT ≥ 30,0 kg/ = obesitas berat. Indeks massa tubuh (IMT) dan osteoporosis berhubungan kuat karena IMT dipercaya sebagai indikator yang dipakai dalam pengukuran densitas mineral tulang (DMT). Tujuan dari penelitllian adalah untuk menentukan hubungan indeks massa tubuh dengan kepadatan mineral tulang collum femur dan tulang vertebra lumbal. Penelitian ini merupakan penelitian potong lintang pada 233 pasien yang menjalani pemeriksaan densitometri di Rumah Sakit Royal Prima Medan tahun 2020 dengan menggunakan alat Radiofrequency Echographic Multi-Spectrometry (REMS). Hasil penelitian ini menunjukkan bahwa adanya hubungan yang signifikan antara Indeks Massa Tubuh (IMT) dengan nilai T-score vertebra lumbal dan T-score collum femur (P <0,000). Dan uji korelasi antara nilai IMT dengan nilai T-score leher femur (r=-.195;p<0.05) dan T-score vertebra lumbal (r= -.179;p<0.05) menunjukkan hubungan yang sangat lemah dan berpola negatif yang artinya semakin rendah IMT maka semakin rendah T-score yang berarti semakin rentan terhadap resiko osteoporosis di leher femur dan tulang belakang. Kata Kunci: Indeks Massa Tubuh (IMT), Osteoporosis, Densitas Mineral Tulang (DMT)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.